Dipyridamole [orch, phsu]
PREVENT [phsu]
Stroke [dsyn]
vascular [bpoc]
Events [evnt]
Patients [podg]
Vascular disease [dsyn]
Withdrawn [fndg]
Paper [mnob]
Art [ocdi]
Background [cnce]
Patients [podg]
Limited [ftcn]
Cerebral Ischemia [dsyn]
Arterial [bpoc]
origin [clas]
Serious Event [qlco]
vascular [bpoc]
Annually [tmco]
Aspirin [orch, phsu]
Risk [qlco]
One [qnco]
Trial [resa]
ADD [mobd]
Dipyridamole [orch, phsu]
Aspirin [orch, phsu]
Associated [qlco]
Risk Reduction [inbe]
Compared [acty]
Aspirin [orch, phsu]
Alone [qnco]
Review, Systematic [inpr]
Trial [resa]
Antiplatelet Agents [phsu]
Collaboration [socb]
Show [inpr]
High Risk [qlco]
Patients [podg]
ASPIRIN/DIPYRIDAMOLE [orch, phsu]
Combination [qlco]
Aspirin [orch, phsu]
Alone [qnco]
objectives [inpr]
To [qlco]
Assess [acty]
Efficacy [qlco]
Safety [hcpp]
Dipyridamole [orch, phsu]
Control [grup]
Secondary Prevention [topp]
vascular [bpoc]
Events [evnt]
Patients [podg]
Vascular disease [dsyn]
search [inpr]
strategy [menp]
Searched [acty]
Stroke [dsyn]
Group [idcn]
Trial [resa]
Searched [acty]
Central [spco]
Controlled [ftcn]
Trial [resa]
Library [mnob, orgt]
Issue [fndg]
MEDLINE [inpr]
contact [ftcn]
Authors [prog]
Pharmaceutical Company [hcro]
search [inpr]
Further [spco]
Data [idcn]
Published [ocac]
studies [lbpr]
Selection Criteria [qlco]
Select [acty]
Long-term [tmco]
secondary [neop]
prevention trials [resa]
Concealed [qlco]
treatment [ftcn]
Allocation [acty]
treatment [ftcn]
More [ftcn]
One [qnco]
month [tmco]
Start [tmco]
Six [qnco]
months [tmco]
Presentation [idcn]
arterial vascular disease [dsyn]
treatment [ftcn]
Dipyridamole [orch, phsu]
Antiplatelet Drugs [phsu]
Compared [acty]
Drug [phsu]
Antiplatelet drug [phsu]
Dipyridamole [orch, phsu]
Data Collection [resa]
Analysis [lbpr]
Two [qnco]
Review [inpr]
Authors [prog]
Select [acty]
Trial [resa]
Inclusion [qlco]
Assessed [acty]
Trial [resa]
Quality [qlco]
Extracted [topp]
Data [idcn]
Data [idcn]
Intention [menp]
TREAT [ftcn]
Main [qlco]
Result [ftcn]
twenty [orch, phsu]
Nine [qnco]
Trial [resa]
included [ftcn]
participants [popg]
vascular [bpoc]
deaths [orgf]
Fatal [qlco]
Non [ftcn]
Fatal [qlco]
vascular [bpoc]
Events [evnt]
Occurred [acty]
Follow-up [fndg]
Compared [acty]
Control [grup]
Dipyridamole [orch, phsu]
Clear [qlco]
Effect [qlco]
vascular [bpoc]
Death [orgf]
Relative Risk [qnco]
Confidence Interval [qnco]
This [euka]
Result [ftcn]
Not [ftcn]
Dose [qnco]
Dipyridamole [orch, phsu]
Type [qlco]
Presenting [idcn]
Vascular disease [dsyn]
Compared [acty]
Control [grup]
Dipyridamole [orch, phsu]
APPEAR [qlco]
To [qlco]
Risk [qlco]
vascular [bpoc]
Events [evnt]
Relative Risk [qnco]
Confidence Interval [qnco]
This [euka]
Effect [qlco]
Only [qnco]
statistically significant [qnco]
Patients [podg]
Presenting [idcn]
Cerebral Ischemia [dsyn]
Authors [prog]
Conclusions [idcn]
Patients [podg]
Presented [idcn]
arterial vascular disease [dsyn]
Evidence [ftcn]
Dipyridamole [orch, phsu]
Presence [topp]
absence [qnco]
Antiplatelet drug [phsu]
Reduced [qlco]
Risk [qlco]
vascular [bpoc]
Death [orgf]
Risk [qlco]
Further [spco]
vascular [bpoc]
Events [evnt]
This [euka]
Benefit [qnco]
Found [qnco]
Only [qnco]
Patients [podg]
Presenting [idcn]
Cerebral Ischemia [dsyn]
Evidence [ftcn]
Dipyridamole [orch, phsu]
Alone [qnco]
More [ftcn]
Efficacy [qlco]
Aspirin [orch, phsu]
